These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21744007)

  • 1. Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population.
    Karabon L; Pawlak-Adamska E; Tomkiewicz A; Jedynak A; Kielbinski M; Woszczyk D; Potoczek S; Jonkisz A; Kuliczkowski K; Frydecka I
    Pathol Oncol Res; 2012 Apr; 18(2):219-26. PubMed ID: 21744007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
    Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
    Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
    Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
    Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
    Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Dinkci S
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
    Jin P; Xiang B; Huang G; Zhou Z
    J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome.
    Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
    Xiong YH; He L; Fei J
    Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
    Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
    Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL; Huang Q; Liu CH; Xie F
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A
    Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
    Fouad NA; Saeed AM; Mahedy AW
    Egypt J Immunol; 2017 Jun; 24(2):63-70. PubMed ID: 29528580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the CTLA-4 single nucleotide polymorphisms CT60G>A and +49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population.
    Łuszczek W; Majorczyk E; Nockowski P; Pluciński P; Jasek M; Nowak I; Wiśniewski A; Kuśnierczyk P
    Int J Immunogenet; 2008 Feb; 35(1):51-5. PubMed ID: 18093182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.